The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Annals of Surgical Oncology

Volumn 23, Issue 1, 2016, Pages 335-342

  Kang, Minyong ^a   Jeong, Chang Wook ^b   Kwak, Cheol ^b   Kim, Hyeon Hoe ^b   Ku, Ja Hyeon ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER LOCALIZATION; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DISSECTION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PELVIS LYMPH NODE; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; CANCER GRADING; CARCINOMA, TRANSITIONAL CELL; FOLLOW UP; LYMPHOCYTE; NEUTROPHIL; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTES; NEOPLASM GRADING; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 84952628956     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4708-8     Document Type: Article

References (30)

1. Stamatakis L, Godoy G, Lerner SP. Innovations in radical cystectomy and pelvic lymph node dissection. Semin Oncol. 2012;39:573–82.
2. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19:666–75.
3. Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013;112:13–25.
4. Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–92.
5. Prasad SM, Decastro GJ, Steinberg GD. Urothelial carcinoma of the bladder: definition, treatment, and future efforts. Nat Rev Urol. 2011;8:631–42.
6. Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):S79–84.
7. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.
8. Kim YW, Kim SK, Kim CS, Kim IY, Cho MY, Kim NK. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer. Anticancer Res. 2014;34:3481–7.
9. Burke RM, Madden KS, Perry SW, Zettel ML, Brown EB III. Tumor-associated macrophages and stromal TNF-alpha regulate collagen structure in a breast tumor model as visualized by second harmonic generation. J Biomed Opt. 2013;18:86003.
10. Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134:2403–13.
11. Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79:1085–91.
12. Viers BR, Boorjian SA, Frank I, et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014;66:1157–64.
13. Hermanns T, Bhindi B, Wei Y, et al. Pretreatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer. 2014;111:444–51.
14. Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PloS One. 2013;8:e58184.
15. Peng W, Li C, Wen TF, et al. Neutrophil-to-lymphocyte ratio changes predict small hepatocellular carcinoma survival. J Surg Res. 2014;192:402–8.
16. Moon KC, Kim M, Kwak C, Kim HH, Ku JH. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder. Ann Surg Oncol. 2014;21:3132–41.
17. Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, Oshi M. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11:337–41.
18. Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013;108:901–7.
19. Park YH, Ku JH, Kwak C, Kim HH. Posttreatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first-line therapy. Springerplus. 2014;3:243.
20. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.
21. Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res. 2013;33:3291–4.
22. Liao W, Zhang J, Zhu Q, et al. Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol. 2014;7:248–55.
23. de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190:1999–2004.
24. Ceylan C, Doluoglu OG, Keles I, Gazel E, Temuçin T, Odabaş Ö, Karalar M. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non–muscle-invasive bladder tumors. Urologia. 2014;81:120–4.
25. Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH. The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy. Br J Cancer. 2015;112:461–7.
26. An X, Ding PR, Li YH, et al. Elevated neutrophil-to-lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15:516–22.
27. De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10:4895–900.
28. Vesely MD, Schreiber RD. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann NY Acad Sci. 2013;1284:1–5.
29. Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A, Pichler M. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol. 2015. doi:10.1007/s00345-015-1494-7.
30. Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013;27:1046–50.